MID-SIZE BIOPHARMA

The Challenge

A biopharmaceutical company was preparing to launch a new indication. The medical review team faced a fundamental problem: they lacked systematic, standardized consistency in medical content review.

Every promotional material, every reference document, every compliance statement—each one was reviewed from scratch. The team relied entirely on individual reviewers' experience and judgment, with no codified standards to guide consistency.

This created three critical gaps:

• No institutional memory: Review knowledge lived in people's heads. A different reviewer meant a different standard. There was no way to ensure consistency across materials or over time.
• No reusability: Each new brand or indication meant starting over. The work done for one product couldn't transfer to the next—every cycle began from zero.
• No scalability: With a new indication on the horizon, content volume would only increase. The "review from scratch" model wasn't going to hold.

The team needed a structured, codified SOP framework—built from the ground up, aligned with their therapeutic area, and designed to be reused across future product launches.

The Solution

ZENO worked with the client's medical review team to build their first-ever structured SOP for medical content review—not a generic template, but a framework tailored to their therapeutic area, their review culture, and their upcoming indication launch.

The process followed five stages:

1. SOP Drafting

ZENO's medical team facilitated a structured review of the client's existing (unwritten) review practices, translating ad-hoc reviewer knowledge into a draft SOP covering core review dimensions.

2. Standard Definition

Each dimension was broken into specific review criteria—what to check, how to check it, and what constitutes a pass or flag. This gave reviewers a consistent reference for the first time.

3. Expert Validation

The client's in-house medical experts reviewed and validated the draft SOP, ensuring it reflected real-world medical standards and therapeutic area requirements.

4. System Configuration

The validated SOP was configured into ZENO's AI-powered review system, creating a structured workflow that enforces the defined standards automatically.

5. Complete SOP Framework

The result: a living, reusable SOP framework—documented, system-enforced, and ready to scale across brands and indications.

The system was built around 8 core review dimensions, covering document format, reference accuracy, claim verification, clinical data interpretation, off-label risk assessment, promotional balance, and more.

The Results

The new SOP framework transformed how the client approached medical content review:

What stood out:

• Review knowledge is now institutionalized: The team's hard-earned review expertise—once locked in individual reviewers' heads—is now documented, structured, and system-enforced
• New indications don't mean starting over: The SOP framework is designed to carry across brands and therapeutic areas. What was built for one launch sets the foundation for the next
• Consistency becomes the default, not the exception: With clear standards and automated enforcement, the "who reviews it" variable no longer determines quality
• AI accuracy earned trust: ≥98% on format validation and >85% overall gave the team confidence that the system was ready for production

"Before this, every review was a fresh conversation. We had no shared reference—just people's memory of what should be checked. The SOP framework changed that. Now we have a standard that carries across everything we do."

— Medical Review Team Lead, Biopharmaceutical Company

What's Next

With the foundational SOP in place, the client is exploring two adjacent directions:

• Expanding to additional therapeutic areas: Applying the same SOP framework to new product launches, accelerating setup from months to weeks
• Introducing AI pre-screening: Building on the SOP foundation to add automated pre-screening capabilities—connecting Case Study 1 to Case Study 2

The SOP framework turned ad-hoc review into a structured, repeatable process. What comes next is scaling it.